Skip to main content
SpringerLink
Log in

ACUTE KIDNEY INJURY

SuPAR: a potential predictive biomarker for acute kidney injury

  • News & Views
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

New data suggest that plasma soluble urokinase receptor (suPAR) might be a predictive biomarker and potential therapeutic target for acute kidney injury (AKI). However, many questions remain regarding the potential of suPAR to inform clinical decision making, identify patients for enrolment in clinical trials and add to the understanding of AKI pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hayek, S. S. et al. Soluble urokinase receptor and acute kidney injury. N. Engl. J. Med. 382, 416–426 (2020).

    Article  CAS  Google Scholar 

  2. American Society of Nephrology Renal Research Report. J. Am. Soc. Nephrol. 16, 1886–1903 (2005).

  3. Griffin, B. R., Gist, K. M. & Faubel, S. Current status of novel biomarkers for the diagnosis of acute kidney injury: a historical perspective. J. Intensive Care Med. 35, 415–424 (2020).

    Article  Google Scholar 

  4. Zarbock, A. et al. Effect of early versus delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN Randomized Clinical Trial. JAMA 315, 2190–2199 (2016).

    Article  CAS  Google Scholar 

  5. Endre, Z. H. et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int. 77, 1020–1030 (2010).

    Article  CAS  Google Scholar 

  6. Meersch, M. et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 43, 1551–1561 (2017).

    Article  CAS  Google Scholar 

  7. Goldstein, S. L. et al. A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children. Kidney Int. 97, 580–588 (2020).

    Article  CAS  Google Scholar 

  8. Koyner, J. L., Zarbock, A., Basu, R. K. & Ronco, C. The impact of biomarkers of acute kidney injury on individual patient care. Nephrol. Dial. Transplant. https://doi.org/10.1093/ndt/gfz188 (2019).

    Article  PubMed  Google Scholar 

  9. Faubel, S. et al. Ongoing clinical trials in AKI. Clin. J. Am. Soc. Nephrol. 7, 861–873 (2012).

    Article  Google Scholar 

  10. Skrypnyk, N. I. et al. IL-6-mediated hepatocyte production is the primary source of plasma and urine neutrophil gelatinase-associated lipocalin during acute kidney injury. Kidney Int. https://doi.org/10.1016/j.kint.2019.11.013 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, University of Colorado, Denver, and Denver Veterans Administration Medical Center, Denver, CO, USA

    Sarah Faubel

Authors
  1. Sarah Faubel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah Faubel.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faubel, S. SuPAR: a potential predictive biomarker for acute kidney injury. Nat Rev Nephrol 16, 375–376 (2020). https://doi.org/10.1038/s41581-020-0276-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41581-020-0276-7

  • Springer Nature Limited

This article is cited by

Search

Navigation